6.
Hage F, Szalai A
. C-reactive protein gene polymorphisms, C-reactive protein blood levels, and cardiovascular disease risk. J Am Coll Cardiol. 2007; 50(12):1115-22.
DOI: 10.1016/j.jacc.2007.06.012.
View
7.
Di Napoli M, Slevin M, Popa-Wagner A, Singh P, Lattanzi S, Divani A
. Monomeric C-Reactive Protein and Cerebral Hemorrhage: From Bench to Bedside. Front Immunol. 2018; 9:1921.
PMC: 6141664.
DOI: 10.3389/fimmu.2018.01921.
View
8.
Islam M, Kang S
. Chemiluminescence detection of label-free C-reactive protein based on catalytic activity of gold nanoparticles. Talanta. 2011; 84(3):752-8.
DOI: 10.1016/j.talanta.2011.02.001.
View
9.
Boras E, Slevin M, Alexander M, Aljohi A, Gilmore W, Ashworth J
. Monomeric C-reactive protein and Notch-3 co-operatively increase angiogenesis through PI3K signalling pathway. Cytokine. 2014; 69(2):165-79.
DOI: 10.1016/j.cyto.2014.05.027.
View
10.
Ridker P, MacFadyen J, Glynn R, Bradwin G, Hasan A, Rifai N
. Comparison of interleukin-6, C-reactive protein, and low-density lipoprotein cholesterol as biomarkers of residual risk in contemporary practice: secondary analyses from the Cardiovascular Inflammation Reduction Trial. Eur Heart J. 2020; 41(31):2952-2961.
PMC: 7453833.
DOI: 10.1093/eurheartj/ehaa160.
View
11.
Avan A, Tavakoly Sany S, Ghayour-Mobarhan M, Rahimi H, Tajfard M, Ferns G
. Serum C-reactive protein in the prediction of cardiovascular diseases: Overview of the latest clinical studies and public health practice. J Cell Physiol. 2018; 233(11):8508-8525.
DOI: 10.1002/jcp.26791.
View
12.
La Gioia A, Fumi M, Fiorini F, Bombara M, La Gioia N, Pancione Y
. Mindray BC-6800 haematological analyser: 3D-DIFF scattergram usefulness in infectious mononucleosis diagnosis. Int J Lab Hematol. 2021; 43(4):581-587.
DOI: 10.1111/ijlh.13552.
View
13.
Del Angel-Pablo A, Buendia-Roldan I, Mejia M, Perez-Rubio G, Nava-Quiroz K, Rojas-Serrano J
. Anti-HLA Class II Antibodies Correlate with C-Reactive Protein Levels in Patients with Rheumatoid Arthritis Associated with Interstitial Lung Disease. Cells. 2020; 9(3).
PMC: 7140697.
DOI: 10.3390/cells9030691.
View
14.
Steiner J, Frodl T, Schiltz K, Dobrowolny H, Jacobs R, Fernandes B
. Innate Immune Cells and C-Reactive Protein in Acute First-Episode Psychosis and Schizophrenia: Relationship to Psychopathology and Treatment. Schizophr Bull. 2019; 46(2):363-373.
PMC: 7442383.
DOI: 10.1093/schbul/sbz068.
View
15.
Yeh E
. CRP as a mediator of disease. Circulation. 2004; 109(21 Suppl 1):II11-4.
DOI: 10.1161/01.CIR.0000129507.12719.80.
View
16.
Ridker P
. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation. 2003; 107(3):363-9.
DOI: 10.1161/01.cir.0000053730.47739.3c.
View
17.
Wu Y, Potempa L, El Kebir D, Filep J
. C-reactive protein and inflammation: conformational changes affect function. Biol Chem. 2015; 396(11):1181-97.
DOI: 10.1515/hsz-2015-0149.
View
18.
Coletta G, Amendola V
. Numerical Modelling of the Optical Properties of Plasmonic and Latex Nanoparticles to Improve the Detection Limit of Immuno-Turbidimetric Assays. Nanomaterials (Basel). 2021; 11(5).
PMC: 8145499.
DOI: 10.3390/nano11051147.
View
19.
Bryan T, Luo X, Bueno P, Davis J
. An optimised electrochemical biosensor for the label-free detection of C-reactive protein in blood. Biosens Bioelectron. 2012; 39(1):94-8.
DOI: 10.1016/j.bios.2012.06.051.
View
20.
Vashist S, Czilwik G, van Oordt T, von Stetten F, Zengerle R, Schneider E
. One-step kinetics-based immunoassay for the highly sensitive detection of C-reactive protein in less than 30 min. Anal Biochem. 2014; 456:32-7.
DOI: 10.1016/j.ab.2014.04.004.
View